Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Cash from Financing Activities (2024 - 2025)

Carlsmed (CARL) has disclosed Cash from Financing Activities for 2 consecutive years, with -$29000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Financing Activities rose 43.14% year-over-year to -$29000.0, compared with a TTM value of $104.5 million through Dec 2025, changed N/A, and an annual FY2025 reading of $100.1 million, up 71.16% over the prior year.
  • Cash from Financing Activities was -$29000.0 for Q4 2025 at Carlsmed, down from $90.7 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $90.7 million in Q3 2025 and bottomed at -$51000.0 in Q4 2024.